BSX vs CTM · P/E 20, rev $10.65B vs rev $52.9M
Boston Scientific Corp (BSX) versus Castellum Inc. (CTM) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Castellum Inc. (CTM) is a information technology services company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported CTM revenue for 2025-12-31 was $52.9M. Net income was -$2.4M. Revenue was up 18.1% from 2024-12-31 to 2025-12-31. CTM currently screens at market cap $67.0M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. CTM currently screens at market cap $67.0M.
Not investment advice. Open the BSX and CTM stock pages for the full models.
Not investment advice.